LOADING
Comparing NVIDIA Corporation (NVDA) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $355.1B |
| P/E Ratio | -- | 115.1 |
| Forward P/E | -- | 14.9 |
| PEG Ratio | -- | 2.63 |
| EPS | -- | $1.25 |
| Revenue Growth (YoY) | -- | 5.1% |
| Profit Margin | -- | 4.8% |
| Return on Equity | -- | 7.0% |
| Dividend Yield | -- | 2.29% |
| Beta | -- | 0.23 |
| 52-Week High | -- | $156.92 |
| 52-Week Low | -- | $75.81 |
| Volume | -- | -- |